د. نيرة الشقنقيرى

    استشاري معمل البيولوجيا الجزئية ورئيس وحدة توافق الانسجة

استشاري معمل البيولوجيا الجزئية ورئيس وحدة توافق الانسجة


استاذ الباثولوجيا الإكلينيكية، المعهد القومى للأورام، جامعة القاهرة

المؤهلات العلمية:

  • دكتوراه الباثولوجيا الاكلينيكية، كلية الطب، جامعة القاهرة.
  • ماجستير الباثولوجيا الاكلينيكية، كلية الطب، جامعة القاهرة.
  • بكالوريوس الطب والجراحة، كلية الطب، جامعة القاهرة.

أبحاث علمية:

  • Clinical significance of immunophenotypic markers in pediatric T- cell Acute lymphoblastic leukemia. Nayera Hamdy, The Journal of the Egyptian National Cancer Institute. 20 (2), 111-120, 2008.
  • Bcl2 protein expression in Egyptian acute myeloid leukemia. Nayera Hamdy, The Journal of the Egyptian National Cancer Institute. 21 (1), 71-76, 2009.
  • High dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next? Nayera Hamdy, J Cancer Res.Clin Oncol. 140 (8) 1359-65, 2014.
  • Vitamin D receptor polymorphism in Egyptian pediatric acute lymphoblastic leukemia correlation with BMD. Nayera Hamdy,Meta Gene. (9) 42-46, 2016.
  • Detection of kit mutation in core binding factor acute myeloid leukemia. Nayera Hamdy,Leukemia research reports (10) 20-25, 2018.
  • HLA Haplotypes In 250 Families: The Baylor Laboratory Results And A Perspective On A Core NGS Testing Model For The 17th International HLA And Immunogenetics Workshop. Nayera Hamdy, Human Immunology, 80, (11), 897-905, 2019.
  • Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML. Nayera Hamdy, Int J Lab Hematol. 2020.
  • Outcome of Core Binding Factor Acute Myeloid Leukemia by Receptor Tyrosine Kinase Mutation. Nayera Hamdy, Clinical Lymphoma, Myeloma & Leukemia,20 (7), 459- 467, 2020.
  • Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children’s Cancer Hospital Egypt, 2007-17. Nayera Hamdy,Clinical Lymphoma, Myeloma & Leukemia 529-539, 2020.
  • Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience. Nayera Hamdy, Pediatric Transplantation. 2020.
  • RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience. Nayera Hamdy, Clinical Lymphoma, Myeloma & Leukemia 368-374, 2020.
  • Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Nayera Hamdy, Clin. Lab. 2021.